About GenBio
GenBio is a biotechnology company dedicated to pioneering next-generation therapies that address the root causes of chronic inflammation and related conditions. By combining advanced biomarker identification with innovative therapeutic strategies, GenBio is committed to delivering safe, effective, and transformative treatments that address urgent unmet medical needs across multiple markets.
CORPORATE
Delaware biotechnology company incorporated in 2018.
Corporate facts remain subject to management confirmation and buyer diligence.
CORPORATE
Delaware biotechnology company incorporated in 2018.
Corporate facts remain subject to management confirmation and buyer diligence.
CORPORATE
Delaware biotechnology company incorporated in 2018.
Corporate facts remain subject to management confirmation and buyer diligence.
CORPORATE
Delaware biotechnology company incorporated in 2018.
Corporate facts remain subject to management confirmation and
buyer diligence.
CORPORATE
Delaware biotechnology company incorporated in 2018.
Corporate facts remain subject to management confirmation and
buyer diligence.
CORPORATE
Delaware biotechnology company incorporated in 2018.
Corporate facts remain subject to management confirmation and
buyer diligence.